MedPath

SEPA III: The Effectiveness Trial

Not Applicable
Completed
Conditions
HIV Prevention
Interventions
Behavioral: SEPA III
Registration Number
NCT02405481
Lead Sponsor
University of Miami
Brief Summary

The study evaluates the effectiveness of SEPA (Salud, Educacion, Prevencion y Autocuidado; Health, Education, Prevention and Self-Care) to increase HIV prevention behaviors and to reduce the incidence of STIs for Hispanic women when delivered in a real-world setting by community agency personnel. The study recruits Hispanic women between the ages of 18 and 50 who are sexually active and are randomized to either SEPA or a Wait-List Control condition.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
320
Inclusion Criteria
  • Hispanic Women,
  • 18 to 50 years old,
  • Sexually active in the past three months
Read More
Exclusion Criteria
  • Non-Hispanic,
  • younger than 18,
  • older than 50,
  • not sexually active
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
SEPA III InterventionSEPA IIISEPA brings together two important theoretical perspectives that will be effective and sustainable for HIV/AIDS prevention among Hispanic women in an inner city environment. The content and learning strategies of SEPA are based on the social cognitive theory and of HIV/AIDS prevention that prior research has shown to be the most effective in increasing HIV/AIDS prevention behaviors, modified to take into account the special needs of Hispanic women related to gender inequality and cultural values and practices. SEPA's conceptual framework integrates the Social Cognitive Model of behavioral change with Freire's Pedagogy of the Oppressed that guides the delivery and contextual tailoring.
Primary Outcome Measures
NameTimeMethod
Condom Use1 year
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of Miami

🇺🇸

Miami, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath